Sensorion (FR0012596468 ? ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent loss disorders, today announces ...

A research team at the University of California San Diego has discovered a novel and promising method of treating arrhythmogenic cardiomyopathy (ACM), a rare inherited heart disease that can strike ...

ZipBio, a biotechnology company pioneering AI-driven protein therapeutics, announced an exclusive license agreement with MeiraGTx Holdings plc , a vertically integrated, clinical-stage genetic ...

Focusing on the establishment of Sino Biological‘s Center for Bioprocessing (C4B) in Houston, it highlights how the ...

Gavi, the global organization that finances and distributes vaccines in poorer countries, finds itself in a funding standoff ...

WVU School of Medicine researchers, backed by a three-year $1.4M National Eye Institute grant, are developing a gene therapy to treat PROM1-linked inherited blindness.

The nonprofit biotech recently licensed the gene therapy from Boston Children's Hospital and plans to bring it to low- and middle-income countries.

The company received FDA clearance to launch a Phase I trial of its therapy, which it says can overcome safety and efficacy concerns related to systemic AAV delivery.

Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global ...

WTOP’s Matt Kaufax takes an even deeper dive into the Smithsonian Natural History Museum’s “Ocean Library” through DNA ...

Researchers in the College of Agriculture, Health and Natural Resources have developed a novel line of bovine embryonic stem ...

enGEN3, a participatory storytelling platform, has formed a strategic partnership with Web3 anime brand Oni Force to develop ...